TO THE EDITOR:We thank Jeong et al. for their thoughtful comments on our recent review article. As discussed, we agree that in selected patients with hilar and intrahepatic cholangiocarcinoma (CCA), liver transplantation (LT) represents an excellent treatment option, achieving good longterm results. However, we would like to emphasize some remarks.So far, the favorable reported outcomes strongly support LT as an interesting strategy to successfully treat patients with very early (≤2 cm) unresectable intrahepatic CCA. Still, as mentioned in their letter, it is important to stress that there is a worldwide need for prospective trials that challenge this theory. This approach also extends to their reported good outcome of HBV‐associated ICC treated with resection and postoperative chemoembolization. Although this study shows interesting results, it exceeds the scope of our review and as previously discussed, prospective clinical trials comparing this to a more definitive treatment option such as LT would better assess the best approach for this patient population.As we enter a new era where the role of LT as a treatment option for other unresectable liver tumors expands beyond hepatocellular carcinoma, further research focusing on inclusion criteria and neoadjuvant and adjuvant treatments is desperately needed. In this manner, the best treatment option for each type of tumor in the different specific scenarios (ie, ICC arising in HBV patients) will potentially be identified.Nicolás Goldaracena, M.D.Andre Gorgen, M.D.Gonzalo Sapisochin, M.D.Multi‐Organ Transplant ProgramDivision of General SurgeryDepartment of SurgeryToronto General HospitalUniversity Health NetworkUniversity of TorontoToronto, Ontario, CanadaREFERENCESGoldaracena N, Gorgen A, Sapisochin G. Current status of liver transplantation for cholangiocarcinoma. Liver Transpl 2018;24:294‐303.Jeong S, Zheng B, Wang J, Chi J, Tong Y, Xia L, et al. Transarterial chemoembolization: a favorable postoperative management to improve prognosis of hepatitis B virus‐associated intrahepatic cholangiocarcinoma after surgical resection. Int J Biol Sci 2017;13:1234‐1241.
Liver Transplantation – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera